Loss of Earning Capacity (Present Value): $ 1,126,794
General Damages: $ 250,000
Full Value of Claim: $14,789,658
3
Ashlynn argued the Department's lien should be $10,046. She calculated this lien
amount via a methodology used in Ahlborn. (Ahlborn, supra, 547 U.S. at p. 274.) The
Department presented no evidence in its opposition to dispute this evidence. It argued
that no statutory or case authority mandated the "rigid mathematical formula" used by
Ashlynn. It claimed its lien was not limited to the past medical care expenses it paid, but
extended to Ashlynn's future care. The Department also asserted its lien should not be
reduced by the amount of attorney fees and costs expended by Ashlynn to obtain the
settlement. The Department stated it would accept 16 percent of the total settlement to
satisfy its lien, or about $150,175.
In her reply, Ashlynn complained the Department failed to provide a rational
alternative method for calculating the lien amount, no court has embraced the
Department's arguments and the Department "plucked" the number "from the air." The
Department then filed a supplemental opposition, which adopted the formula used by
Ashlynn, but eliminated the value of Ashlynn's future medical expenses ($13,201,673)
from the calculation on the grounds it would be paying those future expenses, resulting in
a lien amount of $140,537.
The trial court used the formula set forth by Ashlynn and later adopted by the
Department. Although $85,000 of the settlement proceeds went to Ashlynn's parents, the
court followed Ashlynn's calculations and used the whole $950,000 as the settlement
amount, leading to a result slightly more favorable to the Department. However, it
excluded from the calculation medical expenses the Department would pay on Ashlynn's
4
behalf in the future, but included future expenses for attendant care. It also declined to
reduce the Department's recovery to account for Ashlynn's attorney fees and costs. This
resulted in a lien award of about $15,311. The Department timely appealed. Ashlynn
timely cross-appealed.
DISCUSSION
I. Background Law
Medicaid is a cooperative federal and state program that pays for medical services
to individuals who cannot afford to pay their own medical costs. (Ahlborn, supra, 547
U.S. at p. 275; see 42 U.S.C. § 1396 et seq.) "Under the Medicaid program, the federal
government provides financial assistance to states that voluntarily participate to assist
them in providing health care to needy persons. If a state agrees to establish a Medicaid
plan, the federal government agrees to pay a specific percentage of expenses.
Participating states must comply with federal Medicaid law. One of the laws is that the
state Medicaid agency must seek reimbursement for medical expenses from liable third
parties." (Branson v. Sharp Healthcare, Inc. (2011) 193 Cal.App.4th 1467, 1473-1474
(Branson).) California participates in the Medicaid program through the California
Medical Assistance Program (Medi-Cal) (§ 14000 et seq.). (Branson, at p. 1474.)
In Ahlborn, the United States Supreme Court held that in seeking reimbursement
"the State's assigned rights extend only to recovery of payments for medical care."
(Ahlborn, supra, 547 U.S. at p. 282.) In response to Ahlborn, our Legislature amended
the California statutes governing claims for reimbursements made by the Department for
funds expended on behalf of injured parties by the Medi-Cal program. (Bolanos v.
5
Superior Court (2008) 169 Cal.App.4th 744, 747 (Bolanos).) Namely, from any
settlement, judgment or award obtained by an injured party, the Department is limited to
recovering payments it made for medical expenses. (§ 14124.76, subd. (a).) "In
determining what portion of a settlement, judgment, or award represents payment for
medical expenses, or medical care, provided on behalf of the beneficiary and as to what
the appropriate reimbursement amount to the director should be, the court shall be guided
by . . . Ahlborn . . . and other relevant statutory and case law." (Ibid.) "[W]hen the
settlement, judgment or award does not specify what portion thereof was for past medical
expenses, an allocation must be made in the settlement, judgment or award that indicates
what portion is for past medical expenses as distinct from other damages. The director's
recovery is limited to that portion of the settlement that is allocated to past medical
expenses." (Bolanos, at p. 748.)
Settlements, however, are often not allocated between past medical expenses and
other damages. This was the situation in Ahlborn. (Ahlborn, supra, 547 U.S. at p. 274.)
Thus, the parties in Ahlborn stipulated to the use of a formula (the Ahlborn formula) as an
allocation method. (Id. at p. 281, fn. 10.) Numerous courts have since accepted the
Ahlborn formula as an acceptable method of approximating the amount of medical
expenses. (Lopez v. Daimler Chrysler Corp. (2009) 179 Cal.App.4th 1373, 1378
(Lopez); Lima v. Vouis (2009) 174 Cal.App.4th 242, 260 (Lima); Bolanos, supra, 169
Cal.App.4th at p. 748; see also, In re E.B. (2012) 229 W.Va. 435, 461; Idaho Dep't of
Health & Welfare v. Hudelson (2008) 146 Idaho 439, 446; Lugo v. Beth Israel Med. Ctr.
(N.Y. Sup. Ct. 2006) 13 Misc.3d 681, 687-688.) The Ahlborn formula is the ratio of the
6
settlement to the total claim, when applied to the benefits provided by the Department.
(Bolanos, supra, 169 Cal.App.4th at p. 753.) Expressed mathematically, the Ahlborn
formula calculates the reimbursement due as the total settlement divided by the full value
of the claim, which is then multiplied by the value of benefits provided. (Reimbursement
Due = [Total Settlement ÷ Full Value of Claim] x Value of Benefits Provided.) The
parties' dispute focuses on the variable addressing the full value of Ashlynn's claim;
specifically, whether future attendant care and medical care should be included in this
variable.
Recently, the United States Supreme Court addressed the division of a settlement
between medical and nonmedical expenses for purposes of determining a Medicaid lien
in Wos v. E.M.A. (2013) __ U.S. __, [133 S.Ct. 1391, 185 L.Ed.2d 471] (Wos). In Wos,
our high court reviewed a North Carolina statute that established a conclusive
presumption that when the state's Medicaid expenditures exceed one-third of a
beneficiary's tort recovery, that one-third of the recovery represented compensation for
medical expenses, even if the settlement or verdict expressly allocated a lower percentage
of the judgment to medical expenses. (Id. at pp. 1397-1398.) The court concluded that
"[a]n irrebuttable, one-size-fits-all statutory presumption [was] incompatible with the
Medicaid Act's clear mandate that a State may not demand any portion of a beneficiary's
tort recovery except the share that is attributable to medical expenses." (Id. at p. 1399.)
The Supreme Court recognized that in some cases the parties may stipulate to an
allocation, but where a stipulation does not exist, fair allocations must be decided by the
7
court at a hearing. (Id. at p. 1400.) The Supreme Court cited section 14124.76 as an
example of a statute providing for such a hearing procedure. (Wos, at p. 1401.)
II. Future Attendant Care and Medical Care
1. Additional Facts
The Department presented a declaration from one of its employees, Rhonda
Wyatt, an associate governmental program analyst working in the Third Party Liability
and Recovery Division. Wyatt summarized the type of benefits available to Medi-Cal
beneficiaries. Wyatt reviewed the physician declarations presented by Ashlynn in
support of her motion and "confirm[ed] that the foregoing benefits and services described
in paragraph 5 above encompass all of the benefits and services described in those
declarations."
Ashlynn noted that Wyatt cited no statutes or regulations requiring Medi-Cal to
pay for attendant care or showing that Medi-Cal paid for these expenses in the past. She
complained the Department cited no authority to support its conclusion that it would pay
these future expenses. The trial court issued a tentative ruling that included the
approximately $11.5 million for Ashlynn's future attendant care in its calculation.
After the court issued its tentative ruling the Department presented a declaration
from another of its employees, Alberta Baral. Baral's declaration was virtually identical
to Wyatt's declaration, but added the words "attendant care by an LVN" to the description
of the types of therapies for which Medi-Cal pays. Ashlynn objected to Baral's
declaration as untimely. The trial court sustained Ashlynn's objection to the Baral
declaration.
8
At oral argument, the Attorney General confirmed with the trial court that it
accepted the representation of Ashlynn's counsel that Medi-Cal would not pay for future
attendant care services and thus the value of these services should be included in the
calculation. The court's final ruling on the motion included the value of attendant care
services in its calculation. The trial court, however, eliminated from its calculation the
cost of Ashlynn's future medical care, presumably concluding that Medi-Cal would be
paying for Ashlynn's future medical care.
2. Analysis
The Department does not contest the trial court's use of the Ahlborn formula to
calculate the reimbursement it is due. To the extent the Department continues to assert
the Ahlborn formula is not a one-size-fits-all formula to be applied in all subsequent cases
we note the Department failed to suggest an alternative method for calculating its lien.
The Department's and Ashlynn's respective appeals focus on the value of one of
the variables used in the Ahlborn formula; namely, they dispute the number used by the
trial court for the full value of Ashlynn's claim. The Department asserts the full value of
Ashlynn's claim should not include the amount of her future expenses for attendant care,
estimated to be $11.5 million, as the Department will be paying those future expenses for
Ashlynn through the Medi-Cal program. Eliminating those future expenses from the
calculation results in a much higher ratio, and thus, a much higher recovery by the
Department. Specifically, the Department argues the trial court's factual finding that
Medi-Cal will not pay Ashlynn's $11.5 million in future expenses for attendant care is
contrary to the substantial evidence in the record.
9
Ashlynn contends Wyatt's declaration does not show the Department will or can
pay all of her future attendant care and medical expenses for the rest of her life and these
future expenses should be included in determining the full value of her claim.
Accordingly, she argues we should affirm the trial court's finding that Medi-Cal will not
pay her future attendant care expenses. In her appeal, she asserts we should reverse the
trial court's finding that Medi-Cal will pay her future medical care expenses for the same
reasons she argued above, i.e., Wyatt's declaration does not show the Department will or
can pay all of her future medical expenses for the rest of her life. The Department
responds that the trial court's elimination of the cost of future medical expenses from the
Ahlborn calculation properly interpreted prevailing law. For Ashlynn's appeal, both
parties essentially incorporated by reference their arguments for the Department's appeal.
Accordingly, we discuss both appeals together. Additionally, because both appeals focus
on whether future attendant care and future medical care should be included or excluded
from the Ahlborn calculation, where appropriate, we refer to these future expenses
together as future health care expenses.
The Department asserts the trial court erred when it refused to accept Wyatt's
uncontroverted and sworn declaration attesting that Medi-Cal had approved and would be
paying for Ashlynn's future attendant care. Citing McMillian v. Stroud (2008) 166
Cal.App.4th 692 (McMillian), the Department claims the trial court failed to recognize
that as a debtor, Ashlynn had the burden of proving the Department did not cover and
would not pay for her future attendant care. The Department asserts the matter should be
reversed and remanded with instructions that the trial court accept the Department's
10
sworn testimony that Medi-Cal will pay about $11.5 million for attendant care; thus, the
trial court erred when it excluded these expenses in determining the full value of
Ashlynn's claim. Ashlynn asserts the trial court correctly rejected the Department's
purported promise to pay for future attendant care as speculative. For the same reasons,
she contends the trial court erred when it found that Medi-Cal will pay for all of her
future medical care expenses.
In McMillian, the court analogized the health care agency to a creditor and
concluded that the debtor-benefit recipient bears the burden of proof on the affirmative
defense that the amount demanded to satisfy the lien exceeds what is permitted by law.
(McMillian, supra, 166 Cal.App.4th at p. 701.) Here, Ashlynn moved to reduce the
Department's lien, arguing that the Ahlborn formula applied and presenting evidence
regarding the full value of her claim, including the about $11.5 million for future
attendant care. Ashlynn satisfied her burden of proving the facts essential to her claim
for relief. Lopez, Lima and Bolanos all stand for the proposition that use of the Ahlborn
formula is a reasonable method for calculating the Department's lien. (Ante, part I.)
In opposition to the motion, the Department argued the Ahlborn formula did not
apply. Eventually, in its supplemental opposition, the Department adopted the Ahlborn
formula. The Department presented Wyatt's declaration to support its contention that the
about $11.5 million for future attendant care should be removed from the calculation
because it would be paying these future expenses. Thus, the question before the trial
court was whether the about $11.5 million for future attendant care should be removed
from the calculation based on Wyatt's declaration. The trial court rejected Wyatt's
11
declaration as speculative and included future expenses for attendant care in its
calculation. The question before us is whether the trial court erred when it (1) rejected
Wyatt's declaration as substantial evidence showing the Department would pay Ashlynn's
future attendant care and (2) apparently accepted the declaration as substantial evidence
showing the Department would pay Ashlynn's future medical care.
By presenting Wyatt's declaration, the Department tried to avoid the issue it faced
in Lima. In Lima, the Department impliedly argued it would be responsible for all or a
substantial portion of the plaintiff's future medical expenses. (Lima, supra, 174
Cal.App.4th pp. 261-262.) The Lima court stated: "[The Department's] contention in this
regard is unsupported by authority; Ahlborn, supra, 547 U.S., 268, does not squarely
address the issue, but appears to assume that the lien rights under discussion there related
to amounts actually paid by the state agency on the Medicaid recipient's behalf. Even
assuming, however, that [the Department's] contention concerning future medical
expenses has arguable legal merit, it lacks factual support. The record contains no
evidence on the issue of [the Department's] responsibility for future medical expenses,
much less a commitment by [the Department] to pay such expenses, and the trial court
made no findings on the issue. Thus, regardless of its legal merit, we reject the
contention concerning future medical expenses because of the lack of factual support.
We do not reach the issue of whether [the Department] could theoretically impose a valid
lien on medical expenses it may be required to pay in the future." (Id. at p. 262.)
We agree in theory with the Department's contention that future health care
expenses must be excluded, as a matter of law, in applying the Ahlborn formula to reduce
12
the Department's lien, because if future health care expenses were to be included, the
Department would be forced to accept a lower percentage of its total lien based on the
amount of future benefits that will be paid by Medi-Cal. However, as we shall discuss,
excluding such expenses is contingent on the Department presenting sufficient evidence
that it will in fact pay Ashlynn's expenses as long as she qualifies for the benefits that she
is presently receiving.
The Department presented evidence suggesting it would pay all of Ashlynn's
future health care expenses. Wyatt stated that since 2012 Ashlynn has received and will
continue to receive full scope Medi-Cal benefits as long as her disability exists, that her
Medi-Cal eligibility aid code expressly permits that she will receive full benefits without
any requirement that she share in the cost of that care, and review of the evidence
presented by Ashlynn regarding her future care show this care is included in the full
scope Medi-Cal benefits that Ashlynn is entitled to receive. Ashlynn contends this
showing was insufficient. She argues the Department offered no evidence regarding its
funding forty years in the future, what benefits will be available in the future, or how
future eligibility might be determined for whatever benefits might be available for the
next forty years. She also complains Wyatt does not establish any expertise with regard
to benefit eligibility or benefit determinations, either in the past or for the future.
Ashlynn does not dispute that Medi-Cal is the only foreseeable source of payment
for her future health care expenses. We agree with the Department's argument that it is
inequitable for Ashlynn to use the estimated value of her future health care expenses to
13
reduce the Department's claim as the only evidence in the record shows Medi-Cal will be
paying these expenses. Ashlynn's future health care needs are uncertain and necessarily
based on reasoned assumptions and estimates from health care professionals. Similarly,
the benefits the Department will offer in the future and its future funding for these
benefits is uncertain and can be based on reasonable assumptions and estimates. Stated
differently, it is impossible for either party to predict the future. We believe it is unjust to
require absolute certainty from the Department regarding how Medi-Cal eligibility will
be determined in the future, whether Ashlynn will remain Medi-Cal eligible, what
benefits it will provide in the future and whether funding will exist for these future
benefits. To the extent the trial court required such certainty, it erred.
Nonetheless, as Ashlynn notes, the Department's evidentiary showing was lacking
in a number of respects. Wyatt stated her duties included negotiating and collecting
Medi-Cal liens. Nothing in her declaration suggested any expertise with regard to past or
future benefit eligibility or benefit determinations. Additionally, Wyatt cited no statutes
or regulations requiring that Medi-Cal pay for all her health care needs, showing that
Medi-Cal paid for these expenses in the past or that it is reasonably probable Medi-Cal
will pay all of these expenses in the future. These defects are potentially correctable.
Because we have articulated a new standard, we remand this matter for further
proceedings, including the presentation of additional evidence by either party. Any
declarations must establish the declarant's expertise in Medi-Cal benefits, funding and
eligibility determinations. (Evid. Code, § 720.) The declarations must also be supported
14
with citations to applicable statutes or regulations regarding current Medi-Cal eligibility,
the type of health care currently available under Medi-Cal, past funding to pay for such
health care, and estimated future funding to pay for the type of health care at issue.
Based on the evidence provided, the trial court must make a determination whether it is
reasonably probable the Department will pay Ashlynn's future health care expenses. If
the trial court makes such a finding, it is directed to exclude these expenses from its
Ahlborn calculation.
The Department also asserts the trial court abused its discretion in sustaining
Ashlynn's objection to the admissibility of Baral's declaration as untimely. This
argument is moot based on our conclusion that the matter must be remanded for further
proceedings.
III. Attorney Fees and Costs
Ashlynn contends the trial court erred in not reducing the Department's recovery to
account for the attorney fees and expenses she incurred to create the common settlement
fund from which the Department sought its recovery. She claims that none of the statutes
articulate a waiver of the common fund doctrine. She also notes that the court in Branson
calculated the Department's recovery by including a reduction for attorney fees and costs.
(Branson, supra, 193 Cal.App.3d at p. 1479.)
Before litigation began, the Department proposed that section 14124.72(d) applied
and offered to reduce its lien under this statute to reflect attorney fees and expenses
incurred by Ashlynn, but Ashlynn rejected the offer. It later argued to the trial court that
Ashlynn's reliance on section 14124.72 to support her attorney fees and costs argument
15
was misplaced as this section did not apply per the language of section 14124.785. The
trial court denied Ashlynn's request to reduce the Department's recovery to account for
attorney fees and litigation costs incurred by Ashlynn. The trial court interpreted sections
14124.72, 14124.76, 14124.78 and 14124.785 as barring such a reduction. As we shall
explain, we reject this interpretation and conclude that section 14124.72(d) applies.
Sections 14124.70 et. seq. set for a statutory scheme to determine the Department's
reimbursement amount for benefits paid under Medi-Cal. The Department can obtain
reimbursement by filing an action directly against a third-party tortfeasor (§ 14124.71),
by filing a lien against a beneficiary's settlement, judgment or award (§ 14124.72), or by
intervening in a Medi-Cal beneficiary's action against a third party (§ 14124.73). Section
14124.72(d) provides:
"Where the action or claim is brought by the beneficiary alone and the beneficiary incurs a personal liability to pay attorney's fees and costs of litigation, the director's claim for reimbursement of the benefits provided to the beneficiary shall be limited to the reasonable value of benefits provided to the beneficiary under the Medi-Cal program less 25 percent which represents the director's reasonable share of attorney's fees paid by the beneficiary and that portion of the cost of litigation expenses determined by multiplying by the ratio of the full amount of the reasonable value of benefits so provided to the full amount of the judgment, award, or settlement."
"Prior to Ahlborn, California law specified that the entire amount of a beneficiary's
settlement was available to satisfy a Medi-Cal lien. [Citation and footnote deleted.] In
May 2006, a unanimous Supreme Court in Ahlborn held that a state Medicaid agency
cannot 'lay claim to more than the portion of [the beneficiary's] settlement that represents
medical expenses.' [Citation.] Following Ahlborn, the California Legislature
16
amended . . . sections 14124.76 and 14124.78, effective August 24, 2007. Section
14124.76, subdivision (a) now provides that '[r]ecovery of the director's lien from an
injured beneficiary's action or claim is limited to that portion of a settlement, judgment,
or award that represents payment for medical expenses, or medical care, provided on
behalf of the beneficiary.' Section 14124.76 further provides that all reasonable efforts
shall be made to obtain the Department's advance agreement to a determination of the
portion of a settlement, judgment or award that represents payment for medical expenses
or medical care; in the absence of such advance agreement, the matter is to be submitted
to a court for determination. Section 14124.76 further provides that in determining what
portion of a settlement, judgment or award represents payment for medical expenses or
medical care and what the appropriate reimbursement amount should be, the court is to
be guided by Ahlborn and other relevant statutory and case law." (Espericueta v. Shewry
(2008) 164 Cal.App.4th 615, 623.)
Before Ahlborn, the Department could claim " 'the entire amount of any settlement
of the injured beneficiary's action or claim," with the caveat that "in no event shall
the . . . claim exceed one-half of the beneficiary's recovery after deducting for attorney's
fees, litigation costs, and medical expenses relating to the injury paid for by the
beneficiary.' " (Branson, supra, 193 Cal.App.4th at p. 1474, citing former § 14124.78.)
Following Ahlborn, the California Legislature amended section 14124.78 to read:
" 'Notwithstanding any other provision of law, in no event shall the director recover more
than the beneficiary recovers after deducting, from the settlement, judgment, or award,
attorney's fees and litigation costs paid for by the beneficiary.' " (Branson, at p. 1475,
17
citing current § 14124.78.) Following Ahlborn, the Legislature also added section
14124.785, which provides: " 'The director's recovery is limited to the amount derived
from applying Section 14124.72, 14124.76, or 14124.78, whichever is less.' " (Branson
at p. 1475, citing current § 14124.785.)
We construe statutes with reference to the entire statutory scheme of which they
are a part and sections relating to the same subject must be read together " 'so that the
whole may be harmonized and retain effectiveness.' " (Ford & Vlahos v. ITT
Commercial Finance Corp. (1994) 8 Cal.4th 1220, 1234.) The Department reads section
14124.785 as setting forth three separate methods of apportioning its claim — sections
14124.72(d), 14124.76, subdivision (a) or 14124.78. We reject this assertion as
nonsensical. Rather, as the Bolanos court explained, sections 14124.72(d), 14124.76,
subdivision (a) and 14124.78 set forth limitations on the Department's recovery. Section
14124.76, subdivision (a) limits the director's recovery "to that portion of a settlement,
judgment, or award that represents payment for medical expenses, or medical care,
provided on behalf of the beneficiary." (Bolanos, supra, 169 Cal.App.4th at p. 755.)
Section 14124.72(d) limits the Department's recovery to the "reasonable value of benefits
provided to the beneficiary under the Medi-Cal program less 25 percent" with "benefits"
limited to those expended for medical care and services. (Bolanos, at pp. 756-757.)
Section 14124.78 "imposes a single, absolute limitation on the director's recovery that
precludes the reimbursement of medical expenses from the beneficiary's own resources."
(Id. at p. 757.) As the Bolanos court noted, out of the three limitations set forth in section
14124.785, the most important limitation is that contained in 14124.76. (Id. at p. 757.)
18
Where, as here, the Department filed a lien, section 14124.72(d) sets forth the
method for determining the Department's share of the beneficiary's attorney fees and
costs. Accordingly, the trial court erred when it refused to reduce the Department's lien
to account for the attorney fees and expenses Ashlynn incurred. Because section
14124.72(d) applies, we reject Ashlynn's argument that we should depart from the
statutory scheme and use the common fund doctrine to determine the Department's
contribution to her attorney fees and costs.
IV. Requests for Judicial Notice and Summary
Ashlynn filed a request that we judicially notice (Evid. Code, § 452) or take as
additional evidence (Code Civ. Proc., § 909) Wyatt's deposition testimony in a separate
action to show inconsistency with her declaration. Namely, that Wyatt testified, in part,
that the Department cannot determine Medi-Cal eligibility throughout a person's life
expectancy, state whether Medi-Cal will exist in the future or state what benefits will be
available to Medi-Cal beneficiaries in the future. The Department similarly seeks judicial
notice or presents as additional evidence, its official records showing the amount of
attendant care Ashlynn requires and its payment for these services. These requests are
denied as the materials were not before the trial court and are not relevant to our
resolution of this appeal.
In summary, this matter is remanded to the trial court with directions to (1)
conduct further proceedings regarding whether the cost of Ashlynn's future attendant care
and medical care should be included in its Ahlborn calculation, and (2) apply section
14124.72(d) to determine the Department's share of Ashlynn's attorney fees and costs.
19
DISPOSITION
The order is reversed and the matter is remanded to the trial court for further
proceedings in accordance with this opinion. In the interest of justice, each party will
bear their own costs on appeal.
McINTYRE, J.
WE CONCUR:
HALLER, Acting P. J.
AARON, J.
20
AI Brief
AI-generated · verify before citing
Holding. The court held that while the trial court correctly applied the Ahlborn formula, it erred by failing to reduce the Department's lien for attorney fees and costs under Welfare & Institutions Code section 14124.72(d) and by failing to properly evaluate evidence regarding the exclusion of future health care expenses from the lien calculation. The case is remanded for the trial court to determine if it is reasonably probable the Department will pay for future care and to apply the statutory reduction for attorney fees.
Issues
Whether the trial court erred in its application of the Ahlborn formula by including or excluding future medical and attendant care expenses.
Whether the trial court erred in refusing to reduce the Department's lien to account for the beneficiary's attorney fees and litigation costs under section 14124.72(d).
Disposition. reversed and remanded
Quotations verified verbatim against the opinion
“We conclude the trial court properly employed the methodology used in Arkansas Dept. of Health and Human Services v. Ahlborn (2006) 547 U.S. 268, 274 (Ahlborn), but erred when it refused to reduce the Department's lien to account for the attorney fees and expenses Ashlynn incurred.”
“The trial court interpreted sections 14124.72, 14124.76, 14124.78 and 14124.785 as barring such a reduction. As we shall explain, we reject this interpretation and conclude that section 14124.72(d) applies.”